Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Hao Li, Luqi Li, Xun Qiu, Jing Zhang & Zichun Hua. (2023) The interaction of CFLAR with p130Cas promotes cell migration. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:2, pages 119390.
Crossref
Crossref
Yang Lu, Dashuai Wang, Yaoxi Zhu, Yimei Du, Jinying Zhang & Han Yang. (2022) A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs. Frontiers in Pharmacology 13.
Crossref
Crossref
Ye Miao, Jifeng Liu, Xishu Liu, Qihang Yuan, Hanshuo Li, Yunshu Zhang, Yibo Zhan & Xiaoshi Feng. (2022) Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma. Frontiers in Genetics 13.
Crossref
Crossref
Nikita V. Ivanisenko, Kamil Seyrek, Laura K. Hillert-Richter, Corinna König, Johannes Espe, Kakoli Bose & Inna N. Lavrik. (2022) Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends in Cancer 8:3, pages 190-209.
Crossref
Crossref
Jun Wang, Mingzhi Gong, Zhenggang Xiong, Yangyang Zhao & Deguo Xing. (2021) Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Crossref
A. S. Bavykin. (2021) Cell and molecular level of strategy of COVID-19 to induce immunodeficiency. Possible therapeutic solutions. Journal of microbiology, epidemiology and immunobiology 98:4, pages 450-467.
Crossref
Crossref
Ji Hoon Jang, Tae-Jin Lee, Eon-Gi Sung, In-Hwan Song & Joo-Young Kim. (2021)
Pioglitazone mediates apoptosis in Caki cells via downregulating c‑FLIP
(L)
expression and reducing Bcl‑2 protein stability
. Oncology Letters 22:4.
Crossref
Crossref
Hayriye Verda Erkizan, Shrey Sukhadia, Thanemozhi G. Natarajan, Gustavo Marino, Vicente Notario, Jack H. Lichy & Robert G. Wadleigh. (2021) Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Ji Hoon Jang & Tae-Jin Lee. (2021) The role of microRNAs in cell death pathways. Yeungnam University Journal of Medicine 38:2, pages 107-117.
Crossref
Crossref
Seon Min Woo, Kyoung-jin Min & Taeg Kyu Kwon. (2020) Inhibition of Drp1 Sensitizes Cancer Cells to Cisplatin-Induced Apoptosis through Transcriptional Inhibition of c-FLIP Expression. Molecules 25:24, pages 5793.
Crossref
Crossref
Nikita V. Ivanisenko, Kamil Seyrek, Nikolay A. Kolchanov, Vladimir A. Ivanisenko & Inna N. Lavrik. (2020) The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications. Cell Death Discovery 6:1.
Crossref
Crossref
N. V. Ivanisenko & I. N. Lavrik. (2020) Mathematical Modeling Reveals the Importance of the DED Filament Composition in the Effects of Small Molecules Targeting Caspase-8/c-FLIPL Heterodimer. Biochemistry (Moscow) 85:10, pages 1134-1144.
Crossref
Crossref
Yunda Song, Xuesong Sun, Fangting Duan, Chaobin He, Jiali Wu, Xin Huang, Kaili Xing, Shuxin Sun, Ruiqi Wang, Fengxiao Xie, Yize Mao, Jun Wang & Shengping Li. (2020) SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation. Frontiers in Oncology 10.
Crossref
Crossref
SalmaM Abdelnasser, ShaymaaM M. Yahya, WafaaF Mohamed, MagdyA Gadallah, HalaM Abu Shady, ManalG Mahmoud & MohsenM S. Asker. (2020) Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells. Journal of Cancer Research and Therapeutics 0:0, pages 0.
Crossref
Crossref
Elena Díaz-Rodríguez, Javier Pérez-Peña, Carla Ríos-Luci, Joaquín Arribas, Alberto Ocaña & Atanasio Pandiella. (2019) TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells. Cancer Letters 453, pages 34-44.
Crossref
Crossref
Tobias Luebke, Lisa Schwarz, Yan Yan Beer, Sabrina Schumann, Maria Misterek, Frida Ewald Sander, Carlos Plaza-Sirvent & Ingo Schmitz. (2019) c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma. Cell Death & Disease 10:6.
Crossref
Crossref
Ping Gong, Kun Li, Ying Li, Dan Liu, Linxiang Zhao & Yongkui Jing. (2018) HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue. Cell Death & Disease 9:6.
Crossref
Crossref
Na Zhang, Xiaojia Liu, Lu Liu, Zhesong Deng, Qingxuan Zeng, Weiqiang Pang, Yang Liu, Danqing Song & Hongbin Deng. (2018) Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma. Cell Death & Disease 9:2.
Crossref
Crossref
Martine J. Kallemeijn, Dick de Ridder, Joyce Schilperoord-Vermeulen, Michèle Y. van der Klift, Yorick Sandberg, Jacques J. M. van Dongen & Anton W. Langerak. (2017) Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia. PLOS ONE 12:4, pages e0175670.
Crossref
Crossref
Eun-Ae Kim, Sang-Woo Kim, Jehyun Nam, Eon-Gi Sung, In-Hwan Song, Joo-Young Kim, Taeg Kyu Kwon & Tae-Jin Lee. (2016) Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs. Oncotarget 7:22, pages 31832-31846.
Crossref
Crossref
Kishu Ranjan & Chandramani Pathak. (2016) FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Scientific Reports 6:1.
Crossref
Crossref
Mohammed Elmallah & Olivier Micheau. (2015) Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Marine Drugs 13:11, pages 6884-6909.
Crossref
Crossref
Hongxing Han, Bo Xu, Pengzhi Hou, Chuanwu Jiang, Longxi Liu, Ming Tang, Xiuli Yang, Yunxu Zhang & Yongji Liu. (2015) Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis. Cell Biochemistry and Biophysics 72:2, pages 533-542.
Crossref
Crossref
Simone Fulda. (2015) Targeting apoptosis for anticancer therapy. Seminars in Cancer Biology 31, pages 84-88.
Crossref
Crossref
Simone Fulda. (2015) Targeting extrinsic apoptosis in cancer: Challenges and opportunities. Seminars in Cell & Developmental Biology 39, pages 20-25.
Crossref
Crossref
Mateusz MakowskiKellie J. Archer. (2015) Generalized Monotone Incremental Forward Stagewise Method for Modeling Count Data: Application Predicting Micronuclei Frequency. Cancer Informatics 14s2, pages CIN.S17278.
Crossref
Crossref
Zhong Zheng, Shu Cheng, Wen Wu, Li Wang, Yan Zhao, Yang Shen, Anne Janin & Wei-Li Zhao. (2014) c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
Judith Knievel, Wolfgang Schulz, Annemarie Greife, Christiane Hader, Tobias Lübke, Ingo Schmitz, Peter Albers & Günter Niegisch. (2014) Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer. International Journal of Molecular Sciences 15:11, pages 20500-20517.
Crossref
Crossref
Jessica A. Beach, Laura J. Nary, Rebeka Hovanessian & Rheem D. Medh. (2014) Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells. Biochemical and Biophysical Research Communications 451:3, pages 382-388.
Crossref
Crossref
Fenglin Zang, Xiyin Wei, Xue Leng, Man Yu & Baocun Sun. (2014) C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer. Biochemical and Biophysical Research Communications 450:1, pages 267-273.
Crossref
Crossref
Hui Zhang, Xiuguo Li, Yuanyuan Zhang & Xinyong Luan. (2014) Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells. European Archives of Oto-Rhino-Laryngology 271:6, pages 1653-1659.
Crossref
Crossref
Simone Fulda. 2014. Anticancer Genes. Anticancer Genes
167
180
.
Simone Fulda. 2013. Resistance to Immunotherapeutic Antibodies in Cancer. Resistance to Immunotherapeutic Antibodies in Cancer
157
166
.